Stress Echo Is Losing Its Prognostic Value in Asymptomatic Aortic Stenosis

Neither increase in mean pressure gradient (MPG) nor systolic pulmonary artery pressure (SPAP) at peak exercise predicts outcomes in patients with asymptomatic aortic stenosis (AS) according to a study published in JACC Cardiovascular Imaging.

Continue reading

Discharging Patients Is Safe, the Next Day After Minimalist TAVR

In a recent study published in the Journal of the American College of Cardiology (JACC), it was found that patients undergoing uncomplicated TAVR have a safe next-day discharge (NDD) profile with no difference in 30-day mortality rate in comparison to an increased length of hospital stay. In addition, the study also highlighted better 1-year clinical outcomes in patients as compared to non-NDD group. Continue reading

Assessment of Long-term Outcomes in Patients Undergoing SAVR

A contemporary cohort study recently published in Journal of the American College of Cardiology  highlighted the clinical significance of age and other associated comorbidities in determining the clinical outcome in patients undergoing surgical aortic valve replacement (SAVR). The 10-year mortality rate was found to be considerably high in elderly SAVR recipients of a bioprosthetic valve and almost one-third of the population exhibited subclinical structural valve degeneration (SVD). Continue reading

Leaflet thrombosis in transcatheter and surgical bioprosthetic aortic valves Dr. Raj R. Makkar and Dr. C. Michael Gibson Discuss

Silent cerebral microbleeds during TAVR Dr. Eric Van Belle and Dr. Serge Korjian Discuss

Intersection of coronary artery disease and TAVR Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss

Bivalirudin vs UFH in patients with AFib in TAVR Dr. Usman Baber and Dr. C. Michael Gibson Discuss: BRAVO-3

State of the art in TAVR Dr. Duane Pinto, Dr. Michael Reardon, Dr. James Hermiller and Dr. C. Michael Gibson Discuss

State of the art in mitral valve replacement Dr. Ted Feldman, Dr. Mayra Guerrero and Dr. C. Michael Gibson Discuss

Sildenafil in patients with corrected valvular heart disease and PH Dr. Javier Bermejo and Dr. C. Michael Gibson Discuss

Gender Differences in Outcomes With TAVR Women Undergoing TAVR are at a Decreased Risk of Long-term Mortality

In a recent meta-analysis published in the Journal of the American College of Cardiology, it was found that postoperative complications of Transcatheter Aortic Valve Replacement (TAVR) were different between males and females. While females were at increased risk of short-term complications (within 30 days) such as bleeding, stroke, and vascular complications, they had a lower incidence all-cause mortality within one year of the procedure. Continue reading

Mechanically Expanded vs Self-Expanding TAVR in AS Mechanically Expanded Valves May be a Useful Addition for TAVR

The use of mechanically expandable valves was not inferior to self-expandable valves in high risk patients with severe aortic stenosis enrolled in the REPRISE III clinical trial. The trial results support the potential for the first generation LOTUS valve to become part of regular clinical practice. Continue reading

Sildenafil in Corrected Valvular Heart Disease and Residual PH

Dr. Javier Bermejo and Dr. C. Michael Gibson Discuss

Intersection of Coronary Artery Disease and TAVR

Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss

Effect of Bivalirudin Versus UFH in Patients with AFib in TAVR

Dr. Usman Baber and Dr. C. Michael Gibson Discuss

Intersection of CAD and TAVR

Dr. Duane Pinto, Dr. James Hermiller and Dr. C. Michael Gibson Discuss

State of the Art in Mitral Valve Replacement

Dr. Ted Feldman, Dr. Mayra Guerrero, and Dr. C. Michael Gibson Discuss

Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Aortic Valves

Dr. Raj R. Makkar and Dr. C. Michael Gibson Discuss

TAVR With a Self-Expanding Bioprosthesis Compared With Surgical AVR

Dr. Michael J. Reardon and Dr. Serge Korjian Discuss

Silent Cerebral Microbleeds During TAVR

Dr. Eric Van Belle and Dr. Serge Korjian Discuss